Nebenwirkungen · Idelvion
IDELVION 250 IU powder and solvent for solution for injection IDELVION 500 IU powder and solvent for solution for injection IDELVION 1000 IU powder and solvent for solution for injection IDELVION 2000 IU powder and solvent for solution for injection IDELVION 3500 IU powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 8
HOS-133125 · Präparat HOS-097372
Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-16T12:26:00Z · SHA-256 ef78200b08bf55d95aea60fb381c9af4a418a7f01fe9473c5741f817c39a7895 · Passage 42f7144177697b690f59b1bda795c3fd216297691cf296a2e1269a137feab3cd · Zeichen 3643–3998 im Abschnitt